Replies to post #389961 on Amarin Corp Plc (AMRN)

[dukesking]

As soon as I saw that Teva launched its own generic I thought the exact same thing. Why? Doctors seem uninterested or willing to prescribe it, payers are resisting covering it, prescriptions have stagnated, and it’s been under attack by media and KOLs due to placebo interference.

[Tatsumaki]

Awfully disingenuous of you to claim GL is "poaching Amarin's patent" when it was on market and had blockbuster sales long before V even showed up...

Now look at it this way... GL and GV have essentially the same SHTG label. The sales history of L/GL defines that label's market. If anyone tried to sue GV makers for infringement based on sales volumes alone claiming your Symphony data, they will just show the judge the GL sales history and say "the SHTG label sells 60k+ a week as GL. Our sales of GV dont even come close". That's why they feel there is 0 risk as long as they're not advertising CVD.

[ralphey]

Because Eunucha (formerly AMRN ) is totally impotent ( no pun intended) at stopping such

[Invest83838]

Because they know there is no risk in patent infringement

because the leftist courts already screwed AMRN for good in the USA

So the fruit is ripe for the pickin'

Simple as that